Evaluate BCRX stock safety — financial health, volatility, institutional backing, and risk factors.

What are the risks of investing in BCRX? | Glauxie AI

Q: What are the risks of investing in BCRX?

BioCryst Pharmaceuticals, Inc. (BCRX) operates in the Biotechnology industry (Healthcare sector). The company is led by CEO Charles K. Gayer. BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the... Employees: 435.

Q: How much debt does BCRX have?

Review BCRX total debt, debt-to-equity ratio, interest coverage, and leverage trends.

Q: Is BCRX a good long-term investment?

Evaluate BCRX as a long-term investment using fundamental scores, growth metrics, and risk assessment.

What are the risks of investing in BCRX?

🦉

BioCryst Pharmaceuticals, Inc. (BCRX)

Company Overview

Sector / IndustryHealthcare / Biotechnology

CEOCharles K. Gayer

BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and...

Key Executives

Name	Title
Alane Barnes	Senior Vice President, Chief Legal Officer & Corporate Secretary
Babar Ghias	Chief Financial Officer & Head of Corporate Development
Charles K. Gayer	CEO, President & Director
Jinky Ang Rosselli	Chief Data Innovation Officer
John Ruesch	Chief Technical Operations Officer
Nick Wilder	Manager of Investor Relations

Financial Health

Risk Assessment

Weather Score0/100

RegimeN/A

BCRX Profile Financials

Is BCRX stock safe? How much debt does BCRX have? Is BCRX a good long-term investment?